Liquid embolic for brain vessel malformations
Part of Brain & nervous system, Genetic & congenital, Heart & circulation clinical trials.
This trial tests a new liquid material (called a liquid embolic system) that is injected into the abnormal blood vessels in the brain to block them off. It is for people who have a cerebrovascular malformation and can be treated with a catheter from inside the blood vessel.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a cerebrovascular malformation that can be treated with a catheter procedure from inside the blood vessel.
- You have not had a brain bleed in the past month.
- You do not need other treatments (like surgery or radiation) for the same area at the same time.
- You are not allergic to DMSO, contrast dye, or blood thinners.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a device that delivers a special “embolic” material (often described as glue) to treat a type of abnormal connection in the brain’s blood vessels (dAVF). It may help by blocking the leaking or risky blood flow, and it will be compared against how doctors handle eligible cases with other embolic materials.
This trial tests a liquid embolic agent (a gel-like material) injected into the blood vessels of a brain arteriovenous malformation (AVM) to block abnormal blood flow. It’s for people aged 18 to 80 with certain types of AVMs that doctors think can be treated this way.
This trial studies whether a procedure that blocks the tumor’s blood supply (embolization) can help people with a typical meningioma that is growing or causing symptoms. It may help shrink or control the tumor by cutting off its main blood supply.
This trial tests whether a minimally invasive procedure to block a specific type of abnormal connection between brain blood vessels can help preserve or improve memory and thinking. It is being studied in people who have not yet had bleeding from this condition.
This study looks at whether a simple blood test (called a 'liquid biopsy') can find specific genetic changes in people with cerebral arteriovenous malformations. It aims to help doctors better understand and possibly manage this condition.
This trial compares different materials used during a procedure to treat chronic subdural hematoma, a collection of old blood on the brain's surface. The goal is to see which material works best to prevent the blood from coming back.
Hear when a new Intracranial Arteriovenous Malformations trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.